Table II. Patient characteristics at time of administration of first-line chemotherapy.

CI: Confidence interval; CNS: central nervous system; DFS: disease-free survival; ER: oestrogen receptor; HR: hazard ratio; NAC: prior (neo) adjuvant anthracycline and/or taxane (including anthracycline and taxane-based regimens, anthracycline-based regimen only, and taxane-based regimen only); PB: paclitaxel plus bevacizumab. Bold values show significance